NCT02118792View on ClinicalTrials.gov

Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

764

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Dermatitis, Atopic
Interventions
DRUG

AN2728 Topical Ointment, 2%

DRUG

Matching vehicle control

Trial Locations (1)

Unknown

Anacor Investigational Site, Henrico

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02118792 - Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis | Biotech Hunter | Biotech Hunter